No, Vibrant does not use Western blot or ELISA technology.
Vibrant’s Lyme testing combines both indirect methods (IgG and IgM detection via an immunochip and multiplexed chemiluminescence immunoassay) and direct methods (real-time PCR using probe-based qPCR). This dual approach maximizes the detection of Borrelia species and co-infections across multiple antigen types and genetic targets, improving sensitivity and specificity.
Please consider the following web pages, FAQs, and attached resources to learn more about Vibrant's tickborne technology:
- Why do standard tickborne disease tests fall short?
- https://www.vibrant-wellness.com/test/TickborneDiseases > Additional Resources > Key Clinical Messages > Methodology.
- 2020 scientific study on Vibrant's ultra-high-density protein microarray for high throughput single-tier serological detection of Lyme disease, https://www.nature.com/articles/s41598-020-75036-2
- Can a direct comparison be made between Vibrant's tickborne test and the same markers measured by other laboratories?
- What is the difference between ImmunoBlot and Immunochip? Why does Vibrant use Immunochip
